DAIC Articles

Dec 22, 2017 | DAIC Articles
Enrollment Completed in U.S. IDE Trial for Manta Large Bore Vascular Closure Device

“Essential Medical announced the completion of enrollment in the U.S. pivotal investigational device exemption (IDE) trial of the Manta large bore vascular closure device.”

Dec 19, 2017 | DAIC Articles
Use of Catheter Reprocessing to Reduce Cath and EP Lab Costs

“As payers and other healthcare entities look to better manage costs, especially in the acute care setting, it is important to note that there are some clinical areas where the hospital’s margins are already modest and shrinking.”

Dec 14, 2017 | DAIC Articles
FDA Approves New Indication for NuMed CP Stent System

“The U.S. Food and Drug Administration (FDA) announced clearance for NuMed’s Cheatham Platinum (CP) Stent System, which includes the Covered CP Stent and the Covered Mounted CP Stent.”

Dec 14, 2017 | DAIC Articles
Vasorum Launches Celt ACD Second-Generation Vascular Closure Device in the U.S.

“Vasorum Ltd, the developer and manufacturer of the novel Celt ACD vascular closure device, has added a 7F-sized Celt ACD device to its range following U.S. Food and Drug Administration (FDA) approval of its premarket approval (PMA) supplement.”

Dec 13, 2017 | DAIC Articles
Cordis and Medinol Announce FDA Approval of EluNIR Drug-Eluting Stent System

“Cordis, a Cardinal Health company, and Medinol recently announced U.S. Food and Drug Administration (FDA) approval of the EluNIR drug-eluting stent (DES) for the treatment of patients with narrowing or blockages to their coronary arteries.”

Dec 12, 2017 | DAIC Articles
CorInnova Awarded 2017 InnoSTARS Prize for EpicHeart Soft Robotic Heart Assist Device

“CorInnova Inc. recently announced it was awarded second prize in the “2017 InnoSTARS” life science competition for its EpicHeart soft-robotic heart assist device.”

Nov 25, 2017 | DAIC Articles
First Transcatheter Implant for Diastolic Heart Failure Successful

“Results presented at the 2017 American Heart Association (AHA) Scientific Sessions and published in Circulation show that a new device designed to treat diastolic heart failure is safe and effective.”

Nov 25, 2017 | DAIC Articles
Catastrophic Expenses Common Among Uninsured Heart, Stroke Patients

“The majority of patients without health insurance who were hospitalized for heart attack, stroke or coronary artery bypass graft (CABG) surgery experienced catastrophic healthcare expenses before passage of the Affordable Care Act, according to preliminary research presented at the 2017 American Heart Association (AHA) Scientific Sessions.”

Nov 24, 2017 | DAIC Articles
Titan Nitride Oxide Coated Stent is Noninferior to Synergy Stent

“During a late-breaking session at the European Society of Cardiology (ESC) 2017 meeting, presented study results comparing titan nitride oxide (TiNO) coated stents (Optimax from Hexacath) versus the Synergy bioresorbable polymer coated everolimus-eluting stent (EES) from Boston Scientific, in patients with acute coronary syndrome (ACS) patients.”

Nov 24, 2017 | DAIC Articles
Office-Based Cath Labs May be a New Model for Treating Peripheral Artery Disease

“As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings across the nation, there appears to be very little common ground upon which stakeholders agree. Yet common aspirations that are shared by most participants include better patient care, better clinical outcomes and lower costs.”